Australia’s medical regulators have approved the use of MDMA and psilocybin, better known as magic mushrooms and ecstasy, to treat depression and post-traumatic stress disorder. The Therapeutic Goods Administration said it found “sufficient evidence for potential benefits in certain patients.” Psychiatrists would be able to prescribe the substances only after a thorough diagnosis, and their use would be restricted to clinical trials for now.